NCT02316613View on ClinicalTrials.gov

Prospective Observational Study on the Management of Patients With Relapsed or Refractory Follicular Lymphoma (OLYMPE)

CompletedOBSERVATIONAL
Enrollment

260

Participants

Timeline

Start Date

February 28, 2007

Primary Completion Date

April 30, 2013

Study Completion Date

April 30, 2013

Conditions
Follicular Lymphoma
Interventions
DRUG

Rituximab

Trial Locations (1)

92521

Neuilly-sur-Seine

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT02316613 - Prospective Observational Study on the Management of Patients With Relapsed or Refractory Follicular Lymphoma (OLYMPE) | Biotech Hunter | Biotech Hunter